PET Tracers for Imaging Cardiac Function in Cardio-oncology
Open Access
- 13 January 2022
- journal article
- review article
- Published by Springer Nature in Current Cardiology Reports
- Vol. 24 (3) , 247-260
Abstract
Purpose of Review: Successful treatment of cancer can be hampered by the attendant risk of cardiotoxicity, manifesting as cardiomyopathy, left ventricle systolic dysfunction and, in some cases, heart failure. This risk can be mitigated if the injury to the heart is detected before the onset to irreversible cardiac impairment. The gold standard for cardiac imaging in cardio-oncology is echocardiography. Despite improvements in the application of this modality, it is not typically sensitive to sub-clinical or early-stage dysfunction. We identify in this review some emerging tracers for detecting incipient cardiotoxicity by positron emission tomography (PET).Recent Findings: Vectors labeled with positron-emitting radionuclides (e.g., carbon-11, fluorine-18, gallium-68) are now available to study cardiac function, metabolism, and tissue repair in preclinical models. Many of these probes are highly sensitive to early damage, thereby potentially addressing the limitations of current imaging approaches, and show promise in preliminary clinical evaluations.Summary: The overlapping pathophysiology between cardiotoxicity and heart failure significantly expands the number of imaging tools available to cardio-oncology. This is highlighted by the emergence of radiolabeled probes targeting fibroblast activation protein (FAP) for sensitive detection of dysregulated healing process that underpins adverse cardiac remodeling. The growth of PET scanner technology also creates an opportunity for a renaissance in metabolic imaging in cardio-oncology research.Keywords
Funding Information
- National Cancer Institute (R21CA246409-01)
This publication has 168 references indexed in Scilit:
- Quantitative measurement of mitochondrial membrane potential in cultured cells: calcium‐induced de‐ and hyperpolarization of neuronal mitochondriaThe Journal of Physiology, 2012
- PET/MRI of Inflammation in Myocardial InfarctionJACC, 2012
- The origin of fibroblasts and mechanism of cardiac fibrosisJournal of Cellular Physiology, 2010
- CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarctionProceedings of the National Academy of Sciences, 2010
- Radionuclide Imaging of Myocardial MetabolismCirculation: Cardiovascular Imaging, 2010
- Doxorubicin CardiomyopathyCardiology, 2009
- 11C-meta-hydroxyephedrine defects persist despite functional improvement in hibernating myocardiumJournal of Nuclear Cardiology, 2009
- In Vivo Metabolic Phenotyping of Myocardial Substrate Metabolism in RodentsCirculation: Cardiovascular Imaging, 2009
- What is the mitochondrial permeability transition pore?Journal of Molecular and Cellular Cardiology, 2009
- Doxorubicin Inactivates Myocardial Cytochrome c Oxidase in Rats: Cardioprotection by Mito-QBiophysical Journal, 2009